Target intelligence / Profile preview

KLF3 pseudogene 2 (KLF3P2)

Target
KLF3P2
Molecular classification
Other (pseudogene)
01

Overview

KLF3 pseudogene 2 (KLF3P2) is classified as a pseudogene related to the KLF3 gene, which encodes a transcription factor involved in various biological processes[4]. Pseudogenes like KLF3P2 are generally noncoding remnants of once-functional genes and do not produce functional proteins. No literature, biological function, drug targeting, or disease association has been described for KLF3P2. It should not be considered a therapeutic target. KLF3 itself (not KLF3P2) is a functional transcriptional repressor involved in gene expression regulation, important in processes such as erythropoiesis, metabolism, cardiac development, and immune cell differentiation[1][4]. However, KLF3P2 is distinct from KLF3 and does not encode an active protein[4]. No interacting drugs, therapeutic mechanisms, biomarker roles, or notable safety/therapeutic concerns are associated with KLF3 pseudogene 2. It is not a validated molecular target. KLF3P2 is a pseudogene and not a druggable receptor or therapeutic target. There is no evidence it plays a role in biology, disease, or therapy. If you intended to refer to KLF3 (Kruppel-like factor 3)—a real transcription factor with physiological significance and disease relevance—please clarify, as KLF3 itself is a valid target with a well-established molecular profile[1][4].

Other names
KLF3P2Kruppel-like factor 3 pseudogene 2

Beyond the preview

Go deeper on KLF3 pseudogene 2 (KLF3P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on KLF3 pseudogene 2 (KLF3P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call